Timothy P. Cripe - Concepedia

Author

Timothy P. Cripe

Cincinnati Children's Hospital Medical Center ORCID

Also Known As

&NA;, T Cripe, T P Cripe, T. Cripe, T. P. Cripe, T.P. Cripe, TIMOTHY P. CRIPE, Timothy P. Cripe, Timothy Cripe, Timothy P Cripe

359

Publications

8.2K

Citations

H-Index

123

Concepts

All Affiliations

Cincinnati Children's Hospital Medical Center Nationwide Children's Hospital The Ohio State University University of Cincinnati University of Cincinnati Medical Center

About

Timothy P. Cripe is an author at Cincinnati Children's Hospital Medical Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	39	3.1K
2	Natural Sciences	10	10	1.1K
3	Engineering	2	2	90
4	Health Sciences	2	2	27
5	Nursing	1	1	28

Timothy P. Cripe

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. Kazuo Sasaki, Timothy P. Cripe, Stephen R. Koch, Journal of Biological Chemistry Dominant RoleMolecular BiologyTotal RnaInsulin SignalingTranscriptional Regulation	1984	436
Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. Timothy P. Cripe, Thomas H. Haugen, Johannes Türk, The EMBO Journal Transcriptional RegulationCervical CancerHuman Papillomavirus VaccinesTranscription RegulationPathology	1987	333
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors Walter J. Jessen, Shyra J. Miller, Edwin Jousma, Journal of Clinical Investigation	2012	325
Prognostic factors and outcomes for osteosarcoma: An international collaboration Emilios E. Pakos, Andreas Nearchou, R. J. Grimer, European Journal of Cancer International CollaborationMedicineCancer RegistrationOncologyRadiation Oncology	2009	194
Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. Takaoki Ishiji, Michael J. Lace, Sinikka Parkkinen, The EMBO Journal Transcriptional RegulationCervical Carcinoma CellsCervical CancerImmunologyTranscriptional Enhancer Factor	1992	193
Evidence that a human β-tubulin pseudogene is derived from its corresponding mRNA C. Deborah Wilde, Carol Crowther, Timothy P. Cripe, Nature Protein FunctionProtein ExpressionNatural SciencesGeneticsProtein Biosynthesis	1982	173
A Novel Class of Anticancer Compounds Targets the Actin Cytoskeleton in Tumor Cells Justine Stehn, Nikolas K. Haass, Teresa Bonello, Cancer Research	2013	169
Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients Timothy P. Cripe, Minhtran Ngo, James I. Geller, Molecular Therapy	2014	156
Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group David Walterhouse, Alberto S. Pappo, Jane L. Meza, Journal of Clinical Oncology	2014	153
Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. Timothy P. Cripe, Edward J. Dunphy, Alison Holub, PubMed Synthetic VirologyImmunologyPathologyViral Structural ProteinRms Cell Lines	2001	139

Page 1